Drug Type Biological products |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism ASGPR antagonists(Asialoglycoprotein receptor antagonists), IgG inhibitors(Immunoglobulin G inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Membranous Glomerulonephritis | Preclinical | Switzerland | 26 Oct 2024 | |
Immunoglobulin G4-Related Disease | Preclinical | Switzerland | 26 Oct 2024 |